Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019
Summary
The Publisher's Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Test Kits currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Test Kits pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to:
Summary
The Publisher's Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Test Kits currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Test Kits pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hepatitis Test Kits under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Test Kits and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Test Kits under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
2.1 Hepatitis Test Kits Overview
3 Products under Development
3.1 Hepatitis Test Kits - Pipeline Products by Stage of Development
3.2 Hepatitis Test Kits - Pipeline Products by Segment
3.3 Hepatitis Test Kits - Pipeline Products by Territory
3.4 Hepatitis Test Kits - Pipeline Products by Regulatory Path
3.5 Hepatitis Test Kits - Pipeline Products by Estimated Approval Date
4 Hepatitis Test Kits - Pipeline Products under Development by Companies
4.1 Hepatitis Test Kits Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Test Kits - Pipeline Products by Stage of Development
5 Hepatitis Test Kits Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alderon Biosciences Inc Company Overview
5.2.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AutoGenomics Inc Company Overview
5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 AXO Science SAS Company Overview
5.4.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
5.5 Beckman Coulter Inc Company Overview
5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biokit SA Company Overview
5.6.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biomagnetics Diagnostics Corp Company Overview
5.7.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Bio-Rad Laboratories Inc Company Overview
5.8.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Boditech Med Inc Company Overview
5.9.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 CeMines, Inc. (Inactive) Company Overview
5.10.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cepheid Company Overview
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.12 China Medical Technologies Inc (Inactive) Company Overview
5.12.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.13 Co-Diagnostics Inc Company Overview
5.13.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Corgenix Medical Corp Company Overview
5.14.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 Da An Gene Co Ltd Company Overview
5.15.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Diagnostics for the Real World (Europe) Ltd Company Overview
5.16.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 DiaSorin SpA Company Overview
5.17.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.18 D-Kimia, LLC. Company Overview
5.18.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.19 DNAE Group Holdings Ltd Company Overview
5.19.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Ecoli sro Company Overview
5.20.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview
5.21 Ferrer inCode SL Company Overview
5.21.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview
5.22 Fujirebio Diagnostics Inc Company Overview
5.22.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Genome Diagnostics Pvt. Ltd. Company Overview
5.23.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.24 HealthTell Inc Company Overview
5.24.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Hepron Molecular Lab Inc Company Overview
5.25.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Hologic Inc Company Overview
5.26.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Imperial College London Company Overview
5.27.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.28 LifeAssay Diagnostics (Pty) Ltd Company Overview
5.28.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 MedMira Inc Company Overview
5.29.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Medosome Biotec LLC Company Overview
5.30.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 Monogram Biosciences Inc Company Overview
5.31.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 NanoDiagX Company Overview
5.32.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview
5.33 Ortho-Clinical Diagnostics Inc Company Overview
5.33.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Paramedical Srl Company Overview
5.34.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
5.35 ProteinLogic Ltd Company Overview
5.35.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 Qiagen NV Company Overview
5.36.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.37 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.37.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
5.38 Roche Diagnostics International Ltd Company Overview
5.38.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 Sansure Biotech Inc Company Overview
5.39.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Seegene Inc Company Overview
5.40.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
5.41.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Siemens Healthcare Diagnostics Inc Company Overview
5.42.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.43 Siemens Healthineers AG Company Overview
5.43.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.44 Stanford University Company Overview
5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.45 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview
5.45.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.46 Sysmex Corp Company Overview
5.46.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.47 TBG Diagnostics Ltd Company Overview
5.47.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.48 University Medical Center Hamburg-Eppendorf Company Overview
5.48.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview
5.49 University of British Columbia Company Overview
5.49.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.50 University of Texas Medical Branch at Galveston Company Overview
5.50.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.51 University of Warwick Company Overview
5.51.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
5.52 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
5.52.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.53 Xiamen Zeesan Biotech Co.,Ltd Company Overview
5.53.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Hepatitis Test Kits- Recent Developments
6.1 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights
6.2 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin
6.3 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results
6.4 Nov 06, 2019: OraSure announces 2019 third quarter financial results
6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019
6.6 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results
6.7 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results
6.8 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
6.10 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Hepatitis Test Kits - Pipeline Products by Stage of Development
Table 2: Hepatitis Test Kits - Pipeline Products by Segment
Table 3: Hepatitis Test Kits - Pipeline Products by Territory
Table 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path
Table 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date
Table 6: Hepatitis Test Kits Companies - Pipeline Products by Stage of Development
Table 7: Hepatitis Test Kits - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Alinity i Assay - HCV Ag - Product Status
Table 10: Alinity i Assay - HCV Ag - Product Description
Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status
Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description
Table 13: ARCHITECT c4000 System - HbSAg Assay - Product Status
Table 14: ARCHITECT c4000 System - HbSAg Assay - Product Description
Table 15: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status
Table 16: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description
Table 17: Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: eSystem - Qualitative HCV RNA Assay - Product Status
Table 19: eSystem - Qualitative HCV RNA Assay - Product Description
Table 20: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 22: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 23: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 24: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 25: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Multiplexed Detection - Anti-HCV Antibodies - Product Status
Table 27: Multiplexed Detection - Anti-HCV Antibodies - Product Description
Table 28: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: UniCel DxN - HCV Viral Load Test - Product Status
Table 30: UniCel DxN - HCV Viral Load Test - Product Description
Table 31: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 32: BIO-FLASH anti-HBe Assay - Product Status
Table 33: BIO-FLASH anti-HBe Assay - Product Description
Table 34: BIO-FLASH HAV Assay - Product Status
Table 35: BIO-FLASH HAV Assay - Product Description
Table 36: BIO-FLASH HBe Ag Assay - Product Status
Table 37: BIO-FLASH HBe Ag Assay - Product Description
Table 38: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Test - Hepatitis B - Product Status
Table 40: Diagnostic Test - Hepatitis B - Product Description
Table 41: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: BioPlex 2200 - Hepatitis Test - Product Status
Table 43: BioPlex 2200 - Hepatitis Test - Product Description
Table 44: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: AFIAS-6 - Anti-HBs Test - Product Status
Table 46: AFIAS-6 - Anti-HBs Test - Product Description
Table 47: AFIAS-6 - HBsAg Test - Product Status
Table 48: AFIAS-6 - HBsAg Test - Product Description
Table 49: ichroma Test - Anti-HBs - Product Status
Table 50: ichroma Test - Anti-HBs - Product Description
Table 51: ichroma Test - HBsAg - Product Status
Table 52: ichroma Test - HBsAg - Product Description
Table 53: ichroma Test - HCV - Product Status
Table 54: ichroma Test - HCV - Product Description
Table 55: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Diagnostic Test - Hepatitis C - Product Status
Table 57: Diagnostic Test - Hepatitis C - Product Description
Table 58: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Xpert HCV Quant Assay - Product Status
Table 60: Xpert HCV Quant Assay - Product Description
Table 61: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Diagnostic Assay - HCVA - Product Status
List of Figures
Figure 1: Hepatitis Test Kits - Pipeline Products by Stage of Development
Figure 2: Hepatitis Test Kits - Pipeline Products by Segment
Figure 3: Hepatitis Test Kits - Pipeline Products by Territory
Figure 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path
Figure 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Alderon Biosciences Inc
- AutoGenomics Inc
- AXO Science SAS
- Beckman Coulter Inc
- Biokit SA
- Biomagnetics Diagnostics Corp
- Bio-Rad Laboratories Inc
- Boditech Med Inc
- Cepheid
- Co-Diagnostics Inc
- Corgenix Medical Corp
- Da An Gene Co Ltd
- Diagnostics for the Real World (Europe) Ltd
- DiaSorin SpA
- D-Kimia, LLC.
- DNAE Group Holdings Ltd
- Ecoli sro
- Ferrer inCode SL
- Fujirebio Diagnostics Inc
- Genome Diagnostics Pvt. Ltd.
- HealthTell Inc
- Hepron Molecular Lab Inc
- Hologic Inc
- Imperial College London
- LifeAssay Diagnostics (Pty) Ltd
- MedMira Inc
- Medosome Biotec LLC
- Monogram Biosciences Inc
- NanoDiagX
- Ortho-Clinical Diagnostics Inc
- Paramedical Srl
- ProteinLogic Ltd
- Qiagen NV
- Resultados y Calidad del Sistema Sanitario Publico de Andalucia
- Roche Diagnostics International Ltd
- Sansure Biotech Inc
- Seegene Inc
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Siemens Healthcare Diagnostics Inc
- Siemens Healthineers AG
- Stanford University
- Syamala Srinivasa Life Sciences Pvt. Ltd
- Sysmex Corp
- TBG Diagnostics Ltd
- University Medical Center Hamburg-Eppendorf
- University of British Columbia
- University of Texas Medical Branch at Galveston
- University of Warwick
- Ustar Biotechnologies (Hangzhou) Ltd.
- Xiamen Zeesan Biotech Co.,Ltd
